Adam Harber litigates complex civil and criminal cases, with an emphasis on intellectual property, commercial litigation, and white collar criminal defense.
Adam’s civil practice focuses on intellectual property litigation and related disputes, particularly those concerning software products, pharmaceuticals, and medical devices. His clients in this area have included Pfizer, Google, Dropbox, Intel, Alcon (a subsidiary of Novartis), and C.R. Bard. His intellectual property practice includes representing clients in litigation under the Hatch-Waxman Act and in inter partes review proceedings before the USPTO.
Adam also has defended Fortune 500 companies, major financial institutions, law firms, and senior corporate executives in litigation and arbitration throughout the country.
In his criminal and government investigations practice, Adam has defended clients in investigations by, and litigation against, the Department of Justice, Securities and Exchange Commission, New York Attorney General, and other government agencies. He has experience in matters involving allegations of financial crimes, securities fraud, and anticompetitive conduct.
Adam received his B.S., with honors, from Carnegie Mellon University in 2003 and his J.D., cum laude, from Harvard Law School in 2006, where he was an editor of the Harvard Law Review and argued for the winning team in the 94th Annual Ames Moot Court Competition. Before joining Williams & Connolly in 2007, he served as a law clerk to The Honorable D. Michael Fisher of the United States Court of Appeals for the Third Circuit.
Though all cases vary and none is predictive, Adam’s experience includes:
Intellectual Property Litigation and Related Disputes
- Served as trial counsel to Pfizer in a number of patent cases in the District of Delaware concerning the antibiotic Tygacil®, and represented Pfizer’s subsidiary Wyeth in related inter partes review proceedings. In one of the first pharmaceutical inter partes review cases to proceed to trial and appeal, Wyeth prevailed on all claims and had the finding affirmed by the Federal Circuit.
- Served as trial counsel to Pfizer in litigation in the District of Delaware concerning Pfizer’s platform-technology patent for abuse-resistant opioid drugs, embodied by its Embeda® product.
- Represented Google in patent litigation in the District of Delaware and related inter partes review proceedings.
- Ongoing representation of Dropbox in patent litigation in the Northern District of California and related inter partes review proceedings.
- Defended a medical device company in patent litigation in the Northern District of California, which resulted in a successful jury verdict on all claims. The Federal Circuit reversed the District Court’s ruling on a claim construction issue, and the case subsequently settled.
- Advised Intel regarding several technology and IP-related disputes.
- Defended attorneys accused of legal malpractice relating to their handling of patent prosecution and patent litigation.
Criminal Defense and Government Investigations
- Served as trial counsel for RMBS trader in federal criminal jury trial.
- Ongoing representation of individual client in DOJ and related investigations concerning LIBOR.
- Ongoing representation of individual client in DOJ and SEC securities fraud investigations.
- Represented major telecommunications company in an SEC investigation, which was closed without settlement, charges, or an enforcement action.
- Represented CEO of technology company in indicted securities fraud matter in which the government voluntarily dismissed all charges.
- Served as lead defense counsel in a pro bono felony trial, in which the jury returned a verdict of not guilty on all but a lesser included charge for which the client was sentenced to time served.